Prognostic value of pretreatment
18F-FDG PET/CT in patients with primary malignant melanoma
来瑞鹤,赵莲君,孙一文,滕月,李爱梅,许守林,蒋冲
DOI: https://doi.org/10.3760/cma.j.cn321828-20200915-00345
2022-01-01
Abstract:Objective:To assess the prognostic value of pretreatment
18F-FDG PET/CT metabolic parameters in patients with primary melanoma.
Methods:A retrospective analysis comprised of 35 patients (21 males, 14 females, age: 35-85 years; from January 2014 to August 2019; Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School) who were newly-diagnosed primary melanoma with preoperative
18F-FDG PET/CT was conducted.
18F-FDG PET/CT metabolic parameters including SUV
max, SUV
mean, peak of SUV (SUV
peak) were obtained. Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) of primary focus were measured automatically using the threshold of 40%SUV
max. The optimal thresholds of PET parameters were obtained by using ROC curve analysis. The associations between melanoma-specific survival (MSS), progression-free survival (PFS) and PET/CT metabolic parameters were assessed using Kaplan-Meier method and Cox proportional hazards model.
Results:The median follow-up was 15.4 months, and 20 patients showed disease progression and 7 died. The cut-off values for SUV
max, SUV
mean, SUV
peak, MTV and TLG were 3.95, 2.45, 2.65, 3.60 cm
3 and 14.85 g, respectively (AUCs: 0.742, 0.790, 0.728, 0.655, 0.693;
P values: 0.016, 0.004, 0.022, 0.121, 0.053). Kaplan-Meier method and log-rank test showed that SUV
max, SUV
mean, SUV
peak, MTV and TLG were predictors of PFS (
χ2 values: 4.06-8.35, all
P<0.05). Multivariate analysis showed that MTV (hazard ratio (
HR)=3.09, 95%
CI: 1.08-8.86,
P=0.036) and TLG (
HR=3.36, 95%
CI: 1.11-10.14,
P=0.031) were significant predictors of PFS but not for MSS (
HR=5.14,
P=0.080).
Conclusions:SUV
max, SUV
mean and SUV
peak of primary focus may help for predicting PFS of patients with primary melanoma. MTV and TLG of primary focus may be the best to predict PFS of primary melanoma.